New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Soligenix, Inc.
SNGX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

9M

Biotechnology

Next Earning date - 11 Nov 2024

9M

Biotechnology

Next Earning date - 11 Nov 2024

3.88USD
Shape0.16 ( 4.30%)
favorite-chart

Relative Strenght

7
favorite-chart

Volume Buzz

-57%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

88%

Quote Panel

Shape
Updated October 26, 2024
1W 8.08 % 1M 3.19 % 3M -13.20 % 1Y -50.70 %

Key Metrics

Shape
  • Market Cap

    8.85M


  • Shares Outstanding

    2.28M


  • Share in Float

    2.28M


  • Dividende

    0


  • Earning Date

    11 Nov 2024


  • Price Target

    3.88


  • Average Volume

    144889


  • Beta

    1.842


  • Range

    1.83-32.0


  • Industry

    Biotechnology


  • Website

    https://www.soligenix.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

17.89x

P/S Ratio

1.41x

P/B Ratio

0.8

Debt/Equity

-1423.8%

Net Margin

$-8.0

EPS

How SNGX compares to sector?

P/E Ratio

Relative Strength

Shape

SNGX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$900K

Shape38329%

2025-Revenue

$2.93

Shape-124%

2025-EPS

$900K

Shape48%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-19.19
vs -21.59

Q4.22

arrow
arrow

N/A

-4.58
vs -26.39

Q1.23

arrow
arrow

N/A

-5.76
vs -23.99

Q2.23

arrow
arrow

N/A

-2.72
vs -14.39

Q3.23

arrow
arrow

N/A

-2.56
vs -19.19

Q4.23

arrow
arrow

N/A

-2.56
vs -4.58

Q1.24

arrow
arrow

N/A

-2.88
vs -5.76

Q2.24

arrow
arrow

N/A

-1.31
vs -2.72

Q3.24

arrow
arrow

N/A

-1.39
vs -2.56

Q4.24

arrow
arrow

N/A

-1.25
vs -2.56

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-11%

166.1K  vs 186.2K

Q4.22

arrow
arrow

+33%

366.1K  vs 275.7K

Q1.23

arrow
arrow

+37%

257.2K  vs 188.1K

Q2.23

arrow
arrow

-9%

206.9K  vs 228.6K

Q3.23

arrow
arrow

-21%

130.4K  vs 166.1K

Q4.23

arrow
arrow

-33%

244.8K  vs 366.1K

Q1.24

arrow
arrow

-54%

117K  vs 257.2K

Q2.24

arrow
arrow

-99%

2.3K  vs 206.9K

Q3.24

arrow
arrow

+53%

200K  vs 130.4K

Q4.24

arrow
arrow

-18%

200K  vs 244.8K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-321%

-3.21
vs -0.57

Q4.22

arrow
arrow

+152%

1.52
vs -3.21

Q1.23

arrow
arrow

+31%

0.31
vs 1.52

Q2.23

arrow
arrow

-28%

-0.28
vs 0.31

Q3.23

arrow
arrow

-39%

-0.39
vs -0.28

Q4.23

arrow
arrow

-72%

-0.72
vs -0.39

Q1.24

arrow
arrow

-249%

-2.49
vs -0.72

Q2.24

arrow
arrow

-47%

-0.47
vs -2.49

Institutionnal OwnershipShape

status-upQoQ

Q1.21

arrow
arrow

31

31
vs 31

NA

Q2.21

arrow
arrow

30

30
vs 31

-3%

Q3.21

arrow
arrow

30

30
vs 30

NA

Q4.21

arrow
arrow

24

24
vs 30

-20%

Q1.22

arrow
arrow

29

29
vs 24

21%

Q2.22

arrow
arrow

24

24
vs 29

-17%

Q3.22

arrow
arrow

26

26
vs 24

8%

Q4.22

arrow
arrow

31

31
vs 26

19%

Earnings Growth

Latest News